ORIGINAL ARTICLE. Salvage Surgery After Failure of Nonsurgical Therapy for Carcinoma of the Larynx and Hypopharynx

Similar documents
Wojciech K. Mydlarz, M.D. Pharyngocutaneous Fistulas after Salvage Laryngectomy: Need for Vascularized Tissue

The management of advanced supraglottic and

Self-Assessment Module 2016 Annual Refresher Course

Hiroyuki Hanakawa, Nobuya Monden, Kaori Hashimoto, Aiko Oka, Isao Nozaki, Norihiro Teramoto, Susumu Kawamura

Title. CitationInternational Journal of Clinical Oncology, 20(6): 1. Issue Date Doc URL. Rights. Type. File Information

Treatment and prognosis of patients with recurrent laryngeal carcinoma: a retrospective study

MANAGEMENT OF CA HYPOPHARYNX

RADIO- AND RADIOCHEMOTHERAPY OF HEAD AND NECK TUMORS. Zoltán Takácsi-Nagy PhD Department of Radiotherapy National Institute of Oncology, Budapest 1.

Treatment for Supraglottic Ca History: : Total Laryngectomy y was routine until early 50 s, when XRT was developed Ogura and Som developed the one-sta

Head and Neck Cancer in FA: Risks, Prevention, Screening, & Treatment Options David I. Kutler, M.D., F.A.C.S.

Locoregional recurrences are the most frequent

Does airway intervention before primary nonsurgical therapy for T3/T4 laryngeal squamous cell carcinoma impact on oncological or functional outcomes?

Dr. P. Gullane Wharton Chair Head & Neck Surgery Professor Department of Otolaryngology -Head & Neck Surgery University of Toronto

Persistent tracheostomy after primary chemoradiation for advanced laryngeal or hypopharyngeal cancer

Reconstruction of Hypopharynx and Cervical Oesophagus for Treatment of Advanced Hypopharyngeal Carcinoma and Recurrent Laryngeal Carcinoma

Laryngeal Preservation Using Radiation Therapy. Chemotherapy and Organ Preservation

Treatment and predictive factors in patients with recurrent laryngeal carcinoma: A retrospective study

In early stage (I and II) laryngeal squamous cell carcinoma,

ORIGINAL ARTICLE CHEMOTHERAPY ALONE FOR ORGAN PRESERVATION IN ADVANCED LARYNGEAL CANCER

Surgery in Head and neck cancers.principles. Dr Diptendra K Sarkar MS,DNB,FRCS Consultant surgeon,ipgmer

Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer. American Society of Clinical Oncology Clinical Practice Guideline

Research Article Planned Neck Dissection Following Radiation Treatment for Head and Neck Malignancy

NICE guideline Published: 10 February 2016 nice.org.uk/guidance/ng36

Case Scenario #1 Larynx

QUIZZES WITH ANSWERS FOR COLLECTING CANCER DATA: PHARYNX

Primary and salvage total laryngectomy. Influential factors, complications, and survival

Salivary Glands tumors

Management of Neck Metastasis from Unknown Primary

Salvage Laryngectomy. after R T Failure Indications, Complications and Results. Aug

QUIZZES WITH ANSWERS FOR COLLECTING CANCER DATA: PHARYNX

EFFICACY OF NECK DISSECTION FOR LOCOREGIONAL FAILURES VERSUS ISOLATED NODAL FAILURES IN NASOPHARYNGEAL CARCINOMA

Evaluation and Treatment of Dysphagia in the Head and Neck Cancer Patient

NICE guideline Published: 10 February 2016 nice.org.uk/guidance/ng36

A retrospective review in the management of T3 laryngeal squamous cell carcinoma: an expanding indication for transoral laser microsurgery

Sino-nasal Cancer in Denmark 1982 ± 1991

Cancer of the upper aerodigestive tract: assessment and management in people aged 16 and over

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES

Case Scenario 1. Pathology: Specimen type: Incisional biopsy of the glottis Histology: Moderately differentiated squamous cell carcinoma

The International Federation of Head and Neck Oncologic Societies. Current Concepts in Head and Neck Surgery and Oncology

Stomal Recurrence After Total Laryngectomy

Role of PETCT in the management of untreated advanced squamous cell carcinoma of the oral cavity, oropharynx and hypopharynx

Pharyngocutaneous Fistula Following Laryngectomy

Tumor Volume as a Prognostic Factor for Local Control and Overall Survival in Advanced Larynx Cancer

Laryngeal Conservation

Head and Neck Reirradiation: Perils and Practice

T1/T2 LARYNX CANCER. Click to edit Master Presentation Date. Thomas J Gernon, MD Otolaryngology-Head and Neck Surgery

ANALYSIS OF SECONDARY NECK NODES IN MALIGNANCIES OF UPPER AERODIGESTIVE TRACT

The efficacy of postoperative radiation therapy in patients with carcinoma of the buccal mucosa and lower alveolus with positive surgical margins

ORIGINAL ARTICLE. Lymphatic Metastases to Level IIb in Hypopharyngeal Squamous Cell Carcinoma

SQUAMOUS CELL CARCINOMA OF

Neck Dissection. Asst Professor Jeeve Kanagalingam MA (Cambridge), BM BCh (Oxford), MRCS (Eng), DLO, DOHNS, FRCS ORL-HNS (Eng), FAMS (ORL)

A clinical study of head and neck malignancy in a tertiary hospital

Katsuro Sato. Department of Speech, Language and Hearing Sciences, Niigata University of Health and Welfare, Niigata, Japan

Treatment Results after Primary Radiotherapy with Salvage Surgery in a Series of 1005 Patients

Protocol of Radiotherapy for Head and Neck Cancer

ORIGINAL ARTICLE. Harold Lau, MD; Tien Phan, MD; Jack MacKinnon, MD; T. Wayne Matthews, MD

The Oncologic Safety and Functional Preservation of Supraglottic Partial Laryngectomy

Survey of Laryngeal Cancer at SBUH comparing 108 cases seen here from to the NCDB of 9,256 cases diagnosed nationwide in 2000

Yuzuru Niibe 1, Katsuyuki Karasawa 1, Toshio Mitsuhashi 2 and Yoshiaki Tanaka 3 INTRODUCTION. Jpn J Clin Oncol 2003;33(9)

Protons for Head and Neck Cancer. William M Mendenhall, M.D.

Accepted 28 April 2005 Published online 13 September 2005 in Wiley InterScience ( DOI: /hed.

Effectiveness of Chemoradiotherapy for T1b-T2 Glottic Carcinoma

Survival impact of cervical metastasis in squamous cell carcinoma of hard palate

ACR Appropriateness Criteria Adjuvant Therapy for Resected Squamous Cell Carcinoma of the Head and Neck EVIDENCE TABLE

JOSE FRANCISCO GALLEGOS HERNANDEZ Hospital de Oncología, CMN SXXI. IMSS México City.

LARYNGEAL CANCER AT THE KORLE BU TEACHING HOSPITAL ACCRA GHANA

Thomas Gernon, MD Otolaryngology THE EVOLVING TREATMENT OF SCCA OF THE OROPHARYNX

Adjuvant Therapy in Locally Advanced Head and Neck Cancer. Ezra EW Cohen University of Chicago. Financial Support

MUSCLE - INVASIVE AND METASTATIC BLADDER CANCER

Clinical Discussion. Dr Pankaj Chaturvedi. Professor and Surgeon Tata Memorial Hospital

Considerations in Managing Recurrent Oral Cancer. I have nothing to disclose

Hypopharynx. 1. Introduction. 1.1 General Information and Aetiology

Lymph node ratio as a prognostic factor in head and neck cancer patients

ORIGINAL ARTICLE. Examining the Need for Neck Dissection in the Era of Chemoradiation Therapy for Advanced Head and Neck Cancer

Dr. Tareq Salah Ahmed,MD,ESMO. Lecturer of clinical oncology, Assiut faculty of medicine ESMO accreditation certificate

Organ-Preservation Strategies in head and neck cancer. Teresa Bonfill Abella Oncologia Mèdica Parc Taulí Sabadell. Hospital Universitari

Definitive Chemoradiotherapy Versus Surgery Followed by Adjuvant Radiotherapy in Resectable Stage III/IV Hypopharyngeal Cancer

ORIGINAL ARTICLE. Levels II and III neck dissection for larynx cancer with N0 neck

Enterprise Interest None

CT Findings in Chondroradionecrosis of the Larynx

The International Federation of Head and Neck Oncologic Societies. Current Concepts in Head and Neck Surgery and Oncology

Node-positive hypopharyngeal cancer treated by (chemo)radiotherapy: Impact of upfront neck dissection on outcome, toxicity, and quality of life

Learning Objectives. Head and Neck Cancer: Post-Treatment Changes. Neck Dissection Classification * Radical neck dissection. Radical Neck Dissection

Adenoid Cystic Carcinoma Minor Salivary Gland Origin

Indications and techniques of surgery for the primary treatment of HNSCC

Index. Note: Page numbers of article titles are in boldface type.

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER CERVIX

Head and Neck Cancer 2010 COMPARATIVE AUDIT REPORT

Surgical treatment of hypopharyngeal cancer

Definitive radiotherapy for cervical esophageal cancer

Mick Spillane. Medical. Intensity-Modulated Radiotherapy for Sinonasal Tumors

Squamous cell carcinoma of the nasal vestibule*

journal of medicine The new england Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal Cancer abstract

The International Federation of Head and Neck Oncologic Societies. Current Concepts in Head and Neck Surgery and Oncology

CHAPTER. R. de Bree, L. van der Putten, O.S. Hoekstra, D.J. Kuik, C.A. Uyl-de Groot, H. van Tinteren, C.R. Leemans & M. Boers

Advances in Breast Surgery. Catherine Campo, D.O. Breast Surgeon Meridian Health System April 17, 2015

Clinical analysis of 29 cases of nasal mucosal malignant melanoma

Learning objectives Describe anatomically and clinically the di ifference between laryngeal cancer and hypopharyngeal cancer Be able to describe clini

Transcription:

ORIGINAL ARTICLE Salvage Surgery After Failure of Nonsurgical Therapy for Carcinoma of the Larynx and Hypopharynx Sandro J. Stoeckli, MD; Andreas B. Pawlik, MD; Margareta Lipp, MD; Alexander Huber, MD; Stephan Schmid, MD Background: For larynx preservation, radiotherapy is gaining popularity for primary treatment of laryngeal and hypopharyngeal cancer, reserving surgery for salvage. Objective: To analyze the outcome of salvage surgery after failure of primary radiotherapy. Design: Nine-year retrospective outcome analysis. Setting: University referral center. Patients: Fifty-four patients with squamous cell carcinoma of the larynx (n=39) or hypopharynx (n=15). Results: For laryngeal cancer, mean interval from radiation to detection of recurrence was 14.5 months (range, 2-66 months). Twenty-three patients (59%) presented with a more advanced tumor stage after radiation than at the initial evaluation. Total laryngectomy was needed in 36 patients (92%). Disease-specific 5-year survival rate was 63%. Survival of patients with small recurrent tumors was statistically significantly better than those with advanced tumors (P=.004). For hypopharyngeal cancer, mean interval from radiation to detection of the recurrence was 1 months (range, 3-40 months). Total laryngopharyngectomy was needed in 8 of 9 patients with local recurrrence; neck dissection, in 6 patients with regional recurrence. Disease-specific 5-year survival rate was only 20%. Recurrent tumor and node stages did not influence the outcome. Patients with regional recurrences did no better than those with local ones. Conclusions: Salvage surgery in laryngeal cancer achieves good results, especially for small recurrences. Because of tumor progression, larynx preservation is seldom possible at the time of salvage. Salvage surgery in hypopharyngeal cancer shows poor survival regardless of tumor stage and despite radical surgical procedures, and can be recommended only for carefully selected patients. Arch Otolaryngol Head Neck Surg. 2000;126:1473-1477 From the Clinic of Otorhinolaryngology Head and Neck Surgery (Drs Stoeckli, Pawlik, Huber, and Schmid) and the Clinic of Radiation Oncology (Dr Lipp), University Hospital Zurich, Zurich, Switzerland. LARYNGEAL and hypopharyngeal squamous cell carcinoma (SCC) can be treated effectively with radiotherapy or surgery. Many centers favor radiotherapy in small laryngeal tumors because of the better voice preservation than after partial laryngectomy and in advanced laryngeal and hypopharyngeal tumors because of the larynx preservation. Although organ preservation by means of combined chemotherapy and radiotherapy is gaining more and more popularity, few studies have addressed the clinical course of patients undergoing salvage surgery after radiation therapy failure. The aim of our study was to review the results of surgical salvage after radiation therapy failure in SCC of the larynx and hypopharynx and to determine its indications for the future. RESULTS SCC OF THE LARYNX Of 109 patients with an SCC of the larynx undergoing primary radiation therapy, a local recurrence developed in 44 (40%), and 39 of these patients (37 male; mean age, 62.6 years) underwent salvage surgery. The initial tumors were located in the glottis in 66 patients (61%) and in the supraglottis in 43 patients (39%). After radiotherapy, 25 (38%) of the patients with glottic and 14 (33%) of those with supraglottic carcinoma experienced relapse and underwent salvage surgery. The initial and recurrence TNM stages 1 disclosed 23 patients (59%) presenting with a more advanced tumor stage after radiation than at the initial evaluation (Table 1 and Table 2). There was no statistically different distribution of the initial or the re- 1473

PATIENTS AND METHODS From January 1, 1990, through December 31, 1998, a total of 165 previously untreated patients with an SCC of the larynx or hypopharynx underwent fullcourse radiation therapy and chemotherapy for large or advanced tumors at the University Hospital Zurich, Zurich, Switzerland. Pretreatment workup routinely included panendoscopy and computed tomographic scans. Only patients with potentially resectable initial tumors were entered into the study. Radiotherapy was always administered in a curative intent. Patients treated in a palliative regimen were excluded. All patients underwent planning computed tomography before the onset of the radiation therapy, and the fields were calculated using a computer-guided system. Small (T1 and T2) glottic tumors 1 were radiated in a narrow-field technique including only the larynx. The daily fraction ranged from 1.8 to 2.0 Gy, the weekly dose was 12 Gy, and the total dose ranged from 70 to 72 Gy. Large (T3 and T4) glottic, all supraglottic, and all hypopharyngeal carcinomas were radiated with single doses of 1.2, 1.8, or 2.0 Gy; a weekly dose of 12 Gy; and a total dose ranging from 70 to 74 Gy for the primary site. In the adjuvant situation, 50 Gy of radiation was administered to the cervical lymph nodes bilaterally, and involved nodes received a boost up to a total dose of 66 to 70 Gy. All large tumors were additionally treated with a concomitant chemotherapy with cisplatin in week 1 and 5 of the radiotherapy. Posttreatment survey consisted of 6 weekly clinical controls followed by endoscopy in any case of suspicion of recurrence. Surgical salvage after radiation therapy failure had to be performed in 54 patients (33%) with locoregional recurrence. These patients represent the database of this study. The mean follow-up after salvage surgery was 32.9 months (range, 3-95 months) for the patients with laryngeal cancer and 18.8 months (range, 0-91 months) for the patients with hypopharyngeal cancer. According to the literature, successful salvage surgery was defined as no evidence of disease (NED) for 2 years postoperatively. 2 current TNM stages between the groups with glottic or supraglottic primary tumor. The mean interval from radiation to detection of the recurrence was 14.5 months (range, 2-66 months). The surgical salvage procedure was total laryngectomy in 36 patients (92%) and partial laryngectomy in 3 (8%). All patients underwent wide-field laryngectomy with bilateral neck dissection of the levels II to IV and hemithyroidectomy on the side of the primary tumor. The pharyngeal defect was closed primarily in 35 patients (90%). Four patients needed hypopharyngeal reconstruction with a myocutaneous pectoralis major flap. Postoperative complications were seen in only 11 patients (28%), consisting of pharyngocutaneous fistulas in 5, stomal stenosis in 3, and hypopharyngeal stenosis in 3. Table 1. Clinical Stages of Initial Laryngeal Tumors* Tumor Stage cn0 cn1 cn2 ct1 13 0 0 ct2 14 1 0 ct3 7 1 1 ct4 1 0 1 *Staging system is described in Sobin and Wittekind. 1 Data are given as number of patients (n = 39). Table 2. Recurrent Stages Laryngeal Tumors* Tumor Stage rno rn1 rn2 rt1 2 0 0 rt2 9 0 0 rt3 11 0 1 rt4 15 0 1 *Staging System is described in Sobin and Wittekind. 1 Data are given as number of patients (n = 39). The mean disease-specific 5-year survival rate after salvage surgery for all 39 patients was 63% (Figure 1). No statistically significant difference in survival between patients with initial glottic and supraglottic carcinomas was found. A tendency toward a better outcome of small initial (ct1 and ct2) vs advanced initial (ct3 and ct4) tumors 1 was found (Figure 2), although this difference was statistically not significant (P=.05). There was a statistically significant (P=.004) better survival for the group of patients with low recurrent tumor stages (rt1 and rt2) than for those with advanced stages (rt3 and rt4) (Figure 3). Successful salvage surgery (NED 2 years) was achieved in 21 patients (54%). The overall mortality rate was 49%, with 9 patients (23%) dying of local recurrences, 3 (8%) of lymph node recurrences, 3 (8%) of second primary cancers, 2 (5%) of distant metastasis, and 2 (5%) of other non tumorrelated diseases. SCC OF THE HYPOPHARYNX Of 56 patients undergoing primary radiation therapy for an SCC of the hypopharynx, a locoregional recurrence developed in 33 (59%), but only 15 (13 male and 2 female; mean age, 57.4 years) underwent salvage surgery. All initial primary tumors involved the piriform sinus, and there were no tumors involving only the posterior pharyngeal wall or the postcricoid area. The other patients were not treated further or were referred to palliative chemotherapy because of tumors that were no longer surgically resectable due to tumor progression during and/or after radiotherapy. The initial TNM stages 1 (Table 3) disclosed 13 patients (87%) already presenting with advanced disease (ct3-ct4 and cn2-cn3). 1474

rt1-rt2 rt3-rt4 Figure 1. Disease-specific survival of patients undergoing surgical salvage after radiation therapy failure for squamous cell carcinoma of the larynx (n=39). Figure 3. Comparison of disease-specific survival of patients with recurrent T1 and T2 vs T3 and T4 disease undergoing surgical salvage after radiation therapy failure for squamous cell carcinoma of the larynx. Staging system is described in Sobin and Wittekind. 1 Table 3. Clinical Stages of Initial Hypopharyngeal Tumors* T3-T4 T1-T2 Tumor Stage cn0 cn1 cn2 cn3 ct1 0 0 0 0 ct2 1 1 3 2 ct3 0 0 2 2 ct4 2 1 1 0 *Staging system is described in Sobin and Wittekind. 1 Data are given as number of patients (n = 15). Figure 2. Comparison of disease-specific survival of patients with initial T1 and T2 vs T3 and T4 disease undergoing surgical salvage after radiation therapy failure for squamous cell carcinoma of the larynx. Staging system is described in Sobin and Wittekind. 1 Nine patients (60%) experienced a local recurrence in the hypopharynx and 6 patients (40%), a regional lymph node relapse. The mean interval from radiation to detection of the recurrence was 1 months (range, 3-40 months). The surgical salvage procedure included total laryngopharyngectomy in 8 patients and partial laryngopharyngectomy in 1 patient. These procedures were always combined with a neck dissection of the levels II to IV on the side of the primary tumor. Six patients underwent salvage by means of neck dissection alone. The pharyngeal defect was reconstructed using a myocutaneous pectoralis major flap in 4 patients, a free jejunal graft in 4 patients, and a gastric pull-up procedure in 1 patient. Postoperative complications were seen in 6 patients (40%), consisting of carotid ruptures after carotid reconstruction in 2 patients (causing 1 death), pharyngocutaneous fistula in 1 patient, stomal stenosis in 2 patients, and peripheral deep venous thrombosis in 1 patient. The mean disease-specific 5-year survival rate after salvage surgery for all 15 patients was 20% (Figure 4). There was no significant difference (P=.40) between the groups of patients with inital cn0 or cn1 and initial cn2 or cn3 disease (Figure 5). Interestingly, patients with lymph node recurrence did no better than those with local hypopharyngeal recurrence. Successful salvage surgery (NED 2 years) was possible in only 2 patients (13%). The overall mortality rate was 87%, with 5 patients (33%) dying of local recurrences; 5 patients (33%), lymph node recurrences; 1 patient (6%), second primary cancer; and 2 patients (13%), other non tumor-related diseases. 1475

Figure 4. Disease-specific survival of patients undergoing surgical salvage after radiation therapy failure for squamous cell carcinoma of the hypopharynx (n=15). COMMENT N2-N3 N0-N1 Figure 5. Comparison of disease-specific survival of patients with initial N0 and N1 vs N2 and N3 disease undergoing surgical salvage after radiation therapy failure for squamous cell carcinoma of the hypopharynx (n=15). Staging system is described in Sobin and Wittekind. 1 The treatment of laryngeal and hypopharyngeal cancer by means of primary radiotherapy with the preservation of the functional integrity of the laryngopharyngeal complex is gaining more and more popularity. This concept implies that surgery may be required for salvage after radiation therapy fails. Although it is of paramount importance to obtain information on the outcome of these patients, few studies provide detailed data. This study does not focus on the indication for radiotherapy or the reasons for its failure. The aim of our study was to evaluate the outcome of our patients after salvage surgery. In our group of patients undergoing salvage surgery after radiation therapy failure in laryngeal SCC, a 5-year disease-specific survival rate of 63% was achieved. This result appears favorable in comparison with that of Parsons et al 2 or McLaughlin et al, 3 who report 5-year survival rates of 30% and 41%, respectively. In contrast, Champell and Goepfert 4 and Nibu et al 5 published 5-year survival rates of 64% and 86%, respectively, but only T1 and T2 disease were included in their studies. In agreement with other authors, 6 survival in our series was influenced mainly by the recurrent and not the initial tumor stage. Although there was a considerably large subgroup of patients with small initial tumors that could not be controlled by radiotherapy, partial laryngectomy as a salvage procedure was seldom possible because of tumor progression ending in more advanced recurrent tumor stages. This fact has been underlined by previous studies 7,8 and should always be mentioned to the patients before radiotherapy. The morbidity of salvage laryngectomy in our series was acceptable, with a rather low rate of pharyngocutaneous fistulas compared with that of the literature, 7,9,10 although the radiation dose ranged from 70 to 74 Gy. Despite the performance of a neck dissection in addition to salvage laryngectomy, and although histologically free margins were achieved in all patients, the main cause of death was locoregional recurrence. It seems that the growth pattern of the cancer changes during radiotherapy to a more dissolute one, 11 and in some cases even radical surgical procedures fail to eliminate all tumor cells. 3,7,12,13 Our group of patients with hypopharyngeal carcinoma presented in very advanced initial tumor stages. Although all of them could have been treated surgically, primary radiotherapy was chosen to prevent the sacrifice of the larynx. As in laryngeal cancer, the recurrent tumor stages were shown to be even more advanced, excluding the possibility of surgical salvage in most patients. Those patients who still were candidates for salvage surgery showed a very poor outcome (5-year survival rate, 20%), despite radical surgery with removal of the complete laryngopharyngeal complex in almost all patients. The main cause of death was locoregional recurrence. These results agree strongly with those of previous studies by Davidson et al 6 and Jones, 14 who reported 5-year survival rates of 18% and 23%, respectively. CONCLUSIONS In laryngeal and hypopharyngeal cancer, most recurrent tumors after failure of radiotherapy appear in more advanced stages than at the initial evaluation. This tumor progression prevents partial laryngectomy in almost all cases of laryngeal carcinoma and any salvage surgery in many cases of hypopharyngeal carcinoma. Patients have to know that they cannot expect salvage by means 1476

of surgery in any case of radiation failure, and that salvage surgery means loss of the larynx. In our experience, salvage surgery in laryngeal SCC achieves good survival with a low morbidity rate and therefore can be recommended. Salvage surgery in hypopharyngeal SCC has a very low success rate and should only be performed in carefully selected cases. Accepted for publication June 28, 2000. Presented at the Fourth European Congress of Oto-Rhino-Laryngology, Head and Neck Surgery, Berlin, Germany, May 15, 2000. Corresponding author and reprints: Sandro J. Stoeckli, MD, Clinic of Otorhinolaryngology, Head and Neck Surgery, University Hospital Zurich, Frauenklinikstrasse 24, CH-8091 Zurich, Switzerland (e-mail: stoeckli@orl.usz.ch). REFERENCES 1. Sobin LH, Wittekind C, eds. TNM Classification of Malignant Tumours. 5th ed. New York, NY: John Wiley & Sons; 1997. 2. Parsons JT, Mendenhall WM, Stringer SP, Cassisi NJ, Million RR. Salvage surgery following radiation failure in squamous cell carcinoma of the supraglottic larynx. Int J Radiat Oncol Biol Phys. 1995;32:605-609. 3. McLaughlin MP, Parsons JT, Fein DA, et al. Salvage surgery after radiotherapy failure in T1-T2 squamous cell carcinoma of the glottic larynx. Head Neck. 1996; 18:229-235. 4. Champell BH, Goepfert H. Partial laryngectomy as a salvage procedure for radiation failure. In: Kagan AR, Miles J, eds. Head and Neck Oncology: Clinical Management. New York, NY: Pergamon Press Inc; 1989:91-95. 5. Nibu K, Kamata S, Kawabata K, Nakamizo M, Nigauri T, Hoki K. Partial laryngectomy in the treatment of radiation-failure of early glottic carcinoma. Head Neck. 1997;19:116-120. 6. Davidson J, Keane T, Brown D, et al. Surgical salvage after radiotherapy for advanced laryngopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg. 1997; 123:420-424. 7. Viani L, Stell PM, Dalby JE. Recurrence after radiotherapy for glottic carcinoma. Cancer. 1991;67:577-584. 8. Shamboul K, Doyle-Kelly W, Bailey D. Results of salvage surgery following radical radiotherapy for laryngeal carcinoma. J Laryngol Otol. 1984;98:905-907. 9. McCombe AW, Jones AS. Radiotherapy and complications of laryngectomy. J Laryngol Otol. 1993;107:130-132. 10. Stell PM, Cooney TC. Management of fistulae of the head and neck after radical surgery. J Laryngol Otol. 1974;88:819-834. 11. Norris CM, Peale AR. Partial laryngectomy for irradiation failure. Arch Otolaryngol Head Neck Surg. 1966;84:112-116. 12. Yuen APW, Wie WI, Ho CM. Results of surgical salvage for radiation failure of laryngeal carcinoma. Otolaryngol Head Neck Surg. 1995;112:405-409. 13. Schwaab G, Mamelle G, Lartigau E, Parise O, Wibault P, Luboinski B. Surgical salvage treatment of T1/T2 glottic carcinoma after failure of radiotherapy. Am J Surg. 1994;168:474-475. 14. Jones AS. The management of early hypopharyngeal cancer: primary radiotherapy and salvage surgery. Clin Otolaryngol. 1992;17:545-549. 1477